Concepedia

Efficacy and safety of dolutegravir–rilpivirine for maintenance of virological suppression in adults with HIV-1: 100-week data from the randomised, open-label, phase 3 SWORD-1 and SWORD-2 studies

Michael Aboud, Chloe Orkin, Daniel Podzamczer, Johannes R. Bogner, David Baker, Marie-Aude Khuong-Josses, David Parks, Konstantinos Angelis, Lesley Kahl, Elizabeth A. Blair,

The Lancet HIV · 2019 · 116 citations · 19 references

DOI

Concepts

References

19

Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C

Lesley A. Inker, Christopher H. Schmid, Hocine Tighiouart et al. · New England Journal of Medicine · 2012 · 4.1K citations · Full text

, , +14

UPDATE ON DRUG RESISTANCE MUTATIONS IN HIV-1

&NA; · Infectious Diseases in Clinical Practice · 2001 · 1.7K citations

, , +17

Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202

Grace A. McComsey, Douglas Kitch, Eric S. Daar et al. · The Journal of Infectious Diseases · 2011 · 497 citations · Full text

, , +16

Association of tenofovir exposure with kidney disease risk in HIV infection

Rebecca Scherzer, Michelle M. Estrella, Yongmei Li et al. · AIDS · 2012 · 424 citations

, , +17

Comparison of Changes in Bone Density and Turnover with Abacavir‐Lamivudine versus Tenofovir‐Emtricitabine in HIV‐Infected Adults: 48‐Week Results from the ASSERT Study

Hans‐Jürgen Stellbrink, Chloe Orkin, José Ramón Arribas et al. · Clinical Infectious Diseases · 2010 · 411 citations · Full text

, , +17